Related Experiment Videos
A case report demonstrating spontaneous change in tachycardia terminating window
Pacing and Clinical Electrophysiology : PACE
|September 1, 1984
Summary
A patient-activated pacemaker system successfully terminated drug-resistant ventricular tachycardia. Spontaneous changes in the tachycardia terminating window required adapting pacing modes for effective treatment.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Drug-resistant ventricular tachycardia poses a significant clinical challenge.
- Antitachycardia pacing (ATP) systems offer a therapeutic option for managing ventricular arrhythmias.
- Patient-activated systems provide on-demand therapy for recurrent tachycardias.
Observation:
- A patient with paroxysmal, drug-resistant ventricular tachycardia received a patient-activated pacemaker.
- Initial electrophysiological studies confirmed reproducible tachycardia termination with a two-stimulus interval scanning mode.
- Post-implant, the same pacing mode failed to terminate tachycardia at rest.
Findings:
- A spontaneous change in the tachycardia terminating window was observed.
- A modified pacing mode, utilizing more stimuli, effectively terminated the tachycardia under various physiological conditions.
- This highlights the dynamic nature of ventricular tachycardia and its response to pacing.
Implications:
- Antitachycardia pacemaker systems require adaptable programming to address evolving arrhythmia characteristics.
- The versatility of pacing modes is crucial for sustained efficacy in managing complex ventricular tachycardias.
- This case underscores the importance of ongoing patient monitoring and potential reprogramming of pacing devices.